Immortalized Human Hepatocytes-Ras

Cat.No.: CSC-I9020L

Species: Homo sapiens

Source: Liver

Morphology: Polygonal

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I9020L
Description
Species
Homo sapiens
Source
Liver
Culture Properties
Adherent
Morphology
Polygonal
Immortalization Method
Ras
Application
For Research Use Only
Storage
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.

Note: Never can cells be kept at -20 °C.
Shipping
Dry Ice.
Recommended Products
CSC-C1495 Human Hepatocytes
CIK-HT025 HT® Lenti-Ras V12 Immortalization Kit
Quality Control
Real Time PCR was used to quantify Ras gene expression in immortalized cell line.
BioSafety Level
II
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Immortalized Human Hepatocytes (Ras-transformed) represent a cutting-edge in vitro platform designed to overcome the critical limitations of primary human hepatocytes (PHHs), such as rapid loss of metabolic function and limited proliferative capacity. This cell line is established through the stable expression of the oncogenic Ras(e.g., H-Ras), often in combination with other immortalization factors (like hTERT or SV40 T-antigen), to ensure robust, indefinite expansion while maintaining essential hepatic phenotypes.

  • Exceptional Proliferative Robustness: Unlike PHHs, which suffer from early senescence, the Ras-transformed line provides an inexhaustible cell source. This scalability ensures lot-to-lot consistency, reducing experimental variability and operational costs for large-scale screening.
  • Maintenance of Hepatic Fidelity: These cells retain fundamental hepatocyte characteristics, including the expression of key transcription factors (HNF4α), synthesis of albumin, and crucial phase I/II metabolic enzyme activities. This makes them a superior alternative to hepatocarcinoma-derived lines (like HepG2) which often lack mature metabolic profiles.
  • Enhanced Metabolic and Signaling Studies: The integration of the Ras signaling pathway provides a unique model for investigating Ras-MAPK driven hepatocarcinogenesis, intracellular signaling transduction, and liver regeneration mechanisms.
  • Optimized for Drug Discovery: The cell line serves as a high-fidelity platform for high-throughput screening (HTS) in drug-induced liver injury (DILI) assays, viral hepatitis research (HBV/HCV), and metabolic disease modeling (NAFLD/NASH).

Our Immortalized Human Hepatocytes-Ras offer a powerful, reproducible, and cost-effective solution for pharmaceutical R&D and academic research. By bridging the gap between unstable primary cultures and undifferentiated tumor lines, this product is an essential tool for accelerating the development of next-generation hepatology therapeutics and diagnostic strategies.

ABCC6-Deficient Human Hepatocytes for Studying the Metabolic Characteristics of PXE

Patients affected by the rare disease pseudoxanthoma elasticum (PXE) exhibit the calcification of elastic fibers in ocular, dermal, and vascular tissues. These symptoms are triggered by mutations in the ATP-binding cassette transporter subfamily C member 6 (ABCC6), whose substrate remains unknown. Interestingly, ABCC6 is predominantly expressed in the liver tissue, leading to the hypothesis that PXE is a metabolic disorder. Plümers, Ricarda developed a genome-editing system targeting ABCC6 in human immortalized hepatocytes (HepIms) for further investigations. The HepIms were transfected with an ABCC6-specific clustered regulatory interspaced short palindromic repeat (CRISPR-Cas9) genome-editing plasmid, resulting in the identification of a heterozygous (htABCC6HepIm) and a compound heterozygous (chtABCC6HepIm) clone. These clones were analyzed for key markers associated with the PXE pathobiochemistry. Hints of impaired lipid trafficking, defects in the extracellular matrix remodeling, the induction of calcification inhibitor expression, and the down regulation of senescence and inflammatory markers in ABCC6-deficienct HepIms were found. The ABCC6 knock-out model of HepIms provides a valuable tool for studying the metabolic characteristics of PXE in vitro. The initial analysis of the clones mirrors various features of the PXE pathobiochemistry and provides an outlook on future research approaches.

mRNA expression and Immunofluorescence-based detection of selected markers of ECM remodeling.

Fig. 1. Expression analysis of selected markers of ECM remodeling in wtABCC6HepIm, htABCC6HepIm, and chtABCC6HepIm (Plümers, Ricarda, et al., 2025).

mRNA expression and Immunofluorescence-based detection of selected markers of senescence.

Fig. 2. Analysis of selected markers of senescence in wtABCC6HepIm, htABCC6HepIm, and chtABCC6HepIm (Plümers, Ricarda, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products